2,3-Dimethyl-6-nitro-2H-indazole (CAS No. 444731-73-1) in Pazopanib Intermediates: A Key Compound in Oncology Drug Synthesis
Oct 28, 2025 · 2 min read · Introduction The pharmaceutical industry continues to advance rapidly, focusing on the development of targeted therapies for complex diseases like cancer. Among these therapeutic innovations, Pazopanib has emerged as a significant anti-cancer drug us...
Join discussion
































